| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
4,568 |
3,832 |
$734K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
3,683 |
1,882 |
$139K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
1,798 |
1,515 |
$132K |
| 87481 |
|
2,636 |
2,305 |
$131K |
| 87640 |
|
3,488 |
3,105 |
$85K |
| 87631 |
|
1,074 |
900 |
$80K |
| 87653 |
|
2,804 |
2,484 |
$65K |
| 87641 |
|
3,295 |
2,893 |
$64K |
| 87529 |
|
952 |
883 |
$63K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
2,214 |
1,966 |
$44K |
| 87500 |
|
2,444 |
2,190 |
$44K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,275 |
1,179 |
$43K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,272 |
1,178 |
$43K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
1,542 |
1,374 |
$39K |
| 87486 |
|
1,472 |
1,259 |
$37K |
| 87498 |
|
1,459 |
1,260 |
$37K |
| 87541 |
|
1,458 |
1,259 |
$37K |
| 87581 |
|
1,472 |
1,259 |
$37K |
| 87511 |
|
858 |
777 |
$27K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
320 |
280 |
$25K |
| 87625 |
|
754 |
722 |
$21K |
| 88312 |
|
569 |
535 |
$12K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
438 |
327 |
$9K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
3,340 |
1,755 |
$8K |
| 88304 |
|
570 |
515 |
$5K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
12 |
12 |
$5K |
| 88313 |
|
344 |
318 |
$4K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
61 |
58 |
$3K |
| 87471 |
|
421 |
408 |
$3K |
| 88311 |
|
527 |
497 |
$1K |
| 87563 |
|
44 |
38 |
$1K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
45 |
42 |
$445.59 |
| 81003 |
|
243 |
197 |
$362.83 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
266 |
183 |
$23.46 |